CDC Warns of Drug-Resistant Gonorrhea

the MPR take:

A recent study by the CDC is warning that while rates of gonorrhea have declined since the 1970s, new drug-resistant strains are becoming more prevalent. In their analysis, rates of gonorrhea from 1991–2006 in 17 cities were evaluated and a strong positive association between resistance to the antibiotic ciprofloxacin and gonorrhea incidence rates was found. Although rates of gonorrhea were higher in cities with lower resistance to drugs, cities with a higher resistance had elevated reports of gonorrhea. The CDC no longer recommends ciprofloxacin or other fluoroquinolones as first-line treatment. Because gonococcal susceptibility to cephalosporins has been decreasing (eliminating cefixime as an option),  dual therapy with ceftriaxone and a second antimicrobial drug is the only remaining recommended first-line treatment option for gonorrhea. However, the effectiveness of this regimen may be threatened with the possible emergence and spread of cephalosporin resistance.

CDC Warns of Drug-Resistant Gonorrhea
CDC Warns of Drug-Resistant Gonorrhea
Rates of gonorrhea are higher when more people carry drug-resistant strains of the sexually transmitted disease, according to a forthcoming report by the Centers of Disease Control and Prevention. The study, which will be published in the April 2014 issue of the Emerging Infectious Diseases ...

READ FULL ARTICLE From Time

Loading links....